Osaic Holdings’s Immuneering IMRX Stock Holding History

Osaic Holdings’s Portfolio IMRX Stock Details IMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21	Sell	4 -4,296	-100%	-$22K	﹤0.01%	7720
2025 Q4	$28.3K	Hold	4,300	–	–	﹤0.01%	5624
2025 Q3	$30.1K	Hold	4,300	–	–	﹤0.01%	5652
2025 Q2	$14.5K	Buy	+4,300	New	+$7.37K	﹤0.01%	5936
2024 Q2	–	Sell	-1,000	Closed	-$2.89K	–	7511
2024 Q1	$2.89K	Buy	+1,000	New	+$5.6K	﹤0.01%	6322

Other funds holding IMRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $165M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Osaic Holdings's IMRX Position: Q1 2026 in Review

Osaic Holdings reduced its Immuneering (IMRX) stake by 100% in Q1 2026, selling an estimated $22K and leaving 4 shares worth $21. The position accounts for ﹤0.01% of the portfolio, ranked #7720.

Osaic Holdings first reported a position in IMRX in Q1 2024 and has held it in 5 quarters since. The position peaked at $30.1K in Q3 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

Osaic Holdings held 4 shares of Immuneering worth $21 as of Q1 2026.
Osaic Holdings sold 4,296 Immuneering shares in Q1 2026, an estimated $22K.
Immuneering made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7720 holding.
Osaic Holdings first reported a position in Immuneering in Q1 2024 and has held it in 5 quarters since.
Osaic Holdings's Immuneering position peaked at $30.1K in Q3 2025.
95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.